Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,081,606Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2010 · PS
India International Center for Excellence in Research
$1,080,177Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,080,143Thomas R Hawn · University Of Washington · R33 · FY2022 · AI
New targets against tuberculosis
$1,080,104Deborah T Hung · Broad Institute, Inc. · R01 · FY2020 · AI
Project 1: Mechanisms of Disease Progression
$1,079,976Alan A Aderem · Seattle Children'S Hospital · U19 · FY2020 · AI
IeDEA West Africa Renewal 3
$1,079,838Francois Dabis · Adera · U01 · FY2019 · AI
DOT Diary (D2): Developing a mobile app with combined automated DOT and daily sexual diary for monitoring and improving PrEP adherence
$1,079,742Susan Buchbinder · Public Health Foundation Enterprises · R01 · FY2015 · MH
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
$1,079,424Sara Auld · Emory University · R01 · FY2024 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,078,062Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2008 · PS
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,077,894Thomas R Hawn · University Of Washington · R61 · FY2018 · AI
Seattle Clinical Trials Unit
$1,077,209Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,077,090Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2020 · AI
New targets against tuberculosis
$1,076,804Deborah T Hung · Broad Institute, Inc. · R01 · FY2021 · AI
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
$1,076,287Richard Malley · Boston Children'S Hospital · R01 · FY2019 · AI
Combination Therapy Modeling for M tuberculosis Resistance Suppression and Kill
$1,075,032Arnold Louie · University Of Florida · R56 · FY2014 · AI
Host Determinants of TB Disease Progression
$1,074,740Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2017 · AI
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis
$1,073,841Eric L Nuermberger · Johns Hopkins University · R33 · FY2025 · AI
De facto monotherapy during multidrug TB treatment and emergence of resistance
$1,072,858Veronique Dartois · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
FISH-Flow platform for host-based tuberculosis diagnostics
$1,072,330Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Project 1: Mechanisms of Disease Progression
$1,072,310Alan A Aderem · Seattle Children'S Hospital · U19 · FY2021 · AI
International Tuberculosis Clinical Research
$1,071,829Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Efficacy and cost of HAART DOT in methadone clinics
$1,070,849Julia H. Arnsten · Albert Einstein College Of Medicine · R01 · FY2006 · DA
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,069,255Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2011 · PS
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$1,069,073Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2024 · AI
A STINGing vaccine for TB
$1,068,965William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI